Can stress and trazodone use cause sexsomnia (sleep‑related sexual activity without recall)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Trazodone and Stress Cause Sexsomnia?

Yes, trazodone can potentially contribute to sleep-related sexual behaviors (sexsomnia), though the evidence is limited and primarily relates to benzodiazepine receptor agonists rather than trazodone specifically. While stress alone is a recognized trigger for parasomnias including sexsomnia, the combination with sedating medications may increase risk.

Understanding the Evidence

FDA Warning on Sleep Medications

The FDA has issued warnings regarding benzodiazepine receptor agonist (BzRA) hypnotics being associated with disruptive sleep-related behaviors including sexual behavior 1. However, these warnings specifically target BzRAs (zolpidem, eszopiclone, zaleplon) and benzodiazepines—not trazodone directly.

Trazodone is notably mentioned in guidelines as being used off-label for insomnia without FDA approval, and its efficacy for insomnia is not well established 1. The guidelines actually recommend against using trazodone for chronic insomnia disorder due to weak evidence of efficacy and potential adverse effects 2, 3.

Trazodone's Side Effect Profile

The FDA drug label for trazodone does not specifically list sexsomnia or sleep-related sexual behaviors as documented adverse reactions 4. However, trazodone can cause:

  • Somnolence and sedation
  • Cognitive and motor impairment 4
  • Potential for discontinuation syndrome 4
  • Interaction with other CNS depressants 4

Stress as a Trigger

Stress, sleep deprivation, and psychosocial factors are well-established triggers for NREM parasomnias, including sexsomnia 5, 6, 7. The research consistently identifies:

  • Sleep deprivation
  • Occupational stress
  • Anxiety
  • Alcohol consumption
  • Sleep disruption

as precipitating factors for sexsomnia episodes 8, 6.

Clinical Assessment Framework

Key Features Suggesting Sexsomnia

When evaluating for possible sexsomnia, look for:

  • Complete amnesia for the events (hallmark feature)
  • Emergence from N2/N3 NREM sleep (not REM sleep)
  • Intensification during periods of stress, sleep deprivation, or irregular sleep schedules 8, 6
  • Personal or family history of other NREM parasomnias (sleepwalking, sleep terrors) 8
  • Bed partner corroboration of behaviors during sleep 5, 9

Critical Distinctions

Sexsomnia is a disorder of arousal from NREM sleep characterized by state dissociation—motor activation occurs while cortical awakening remains incomplete 7. This differs fundamentally from:

  • Conscious sexual behavior during wakefulness
  • REM sleep behavior disorder (which involves dream enactment from REM sleep)
  • Psychiatric conditions with sexual disinhibition

Management Approach

Immediate Steps

  1. Discontinue or reassess trazodone use if sexsomnia behaviors emerged after starting the medication, though this is not a documented association in the literature

  2. Address sleep hygiene and stress management aggressively:

    • Regular sleep schedule
    • Adequate sleep duration (avoid sleep deprivation)
    • Stress reduction techniques
    • Avoid alcohol and other CNS depressants 6
  3. Implement safety measures for the patient and bed partner 10

Pharmacological Considerations

If sexsomnia persists after addressing triggers:

  • Melatonin (3-15 mg) is a first-line option with minimal sedation, particularly appropriate for older patients 10, 6
  • Clonazepam (0.5-1 mg at bedtime) is the most established treatment for NREM parasomnias, though it carries risks in elderly patients 11, 10
  • Certain antidepressants (SSRIs, vortioxetine) have shown benefit in case reports 8

Important Caveats

Medications that can trigger or worsen parasomnias include:

  • Zolpidem and other BzRAs 6
  • Quetiapine 6
  • Tricyclic antidepressants, MAOIs, and SSRIs (can induce REM behavior disorder, not typically sexsomnia) 11

The relationship between trazodone specifically and sexsomnia is not established in the medical literature. However, given that trazodone is a sedating medication with CNS effects and that guidelines recommend against its use for insomnia 2, 3, switching to evidence-based treatments for the underlying sleep complaint would be prudent.

Diagnostic Workup

If the diagnosis remains unclear or behaviors persist:

  • Polysomnography to document sleep architecture and capture episodes 7, 9
  • Rule out obstructive sleep apnea (a known trigger) 7
  • Neurological evaluation if atypical features present 11

The combination of stress and sedating medications like trazodone could theoretically create conditions favoring parasomnia emergence through sleep disruption and altered arousal thresholds, even without direct causation.

References

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Research

Sleep-Related Eating Disorder and Sexsomnia; Two Rare Parasomnias? A Mini-Review with Illustrative Case-Reports.

International journal of sexual health : official journal of the World Association for Sexual Health, 2025

Research

Sexsomnia - a detailed approach to evaluation.

Frontiers in sleep, 2026

Guideline

management of rem sleep behavior disorder: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.